Stroke Risk Analysis, a System With a High Detection Rate of Atrial Fibrillation in Stroke and Transient Ischemic Attack.


Journal

Stroke
ISSN: 1524-4628
Titre abrégé: Stroke
Pays: United States
ID NLM: 0235266

Informations de publication

Date de publication:
01 2020
Historique:
pubmed: 18 12 2019
medline: 15 4 2020
entrez: 18 12 2019
Statut: ppublish

Résumé

Background and Purpose- Stroke Risk Analysis (SRA) comprises an algorithm for automated analysis of ECG monitoring, enabling the detection of paroxysmal atrial fibrillation (pxAF) and identifying patterns indicating a high risk of atrial fibrillation (R_AF). We compared Holter-enabled continuous ECG monitoring in combination with SRA (hSRA) with standard continuous ECG monitoring for pxAF detection in patients with acute ischemic stroke. Also, we sought to identify whether the detection of R_AF patterns during the first cycle (first 2 hours) of hSRA recording was associated with the detection of pxAF during the Stroke Unit stay. Methods- We enrolled 524 consecutive patients admitted in the Stroke Unit with acute ischemic stroke or transient ischemic attack with neither history of AF nor AF at admission into a prospective multicentric observational analytic clinical study with intrapatient comparison, who received both continuous ECG monitoring as well as hSRA up to 7 days. Investigators were blinded to hSRA results unless pxAF was detected on SRA. Results- Of the 524 consecutive acute stroke patients (median age, 70.0 years; 60% male; acute ischemic stroke 93%, transient ischemic attack 7%), 462 were eligible and included in the study. Among 462 patients with hSRA available for 66 hours, AF was documented by hSRA in 79 patients (17.1%). From this group, 45 AF cases (9.7%) were confirmed after review by an independent and blinded cardiologist. continuous ECG monitoring detected 21 AF cases (4.3%;

Identifiants

pubmed: 31842722
doi: 10.1161/STROKEAHA.119.026354
doi:

Types de publication

Clinical Trial Comparative Study Journal Article Multicenter Study Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

262-267

Auteurs

Meritxell Gomis (M)

From the Department of Neurosciences, Hospital Universitari Germans Trias i Pujol, Neurosciences, Badalona-Barcelona, Spain (M.G., A.D., L.M.-N., J.A.-B.).

Antoni Dávalos (A)

From the Department of Neurosciences, Hospital Universitari Germans Trias i Pujol, Neurosciences, Badalona-Barcelona, Spain (M.G., A.D., L.M.-N., J.A.-B.).

Francisco Purroy (F)

Department of Neurology, Hospital Arnau de Vilanova, Lleida, Spain (F.P., I.B.).

Pere Cardona (P)

Department of Neurology, Hospital de Bellvitge, Hospitalet de Llobregat-Barcelona, Spain (P.C., B.L.-R., A.P).

Ana Rodríguez-Campello (A)

Department of Neurology, Hospital de Mar, Barcelona, Spain (A.R.-C., E.C.-G., J.R.).

Joan Martí-Fábregas (J)

Department of Neurology, Hospital de Sant Pau, Barcelona, Spain (J.M.-F., A.M.-D.).

Jorge Pagola (J)

Department of Neurology, Hospital Vall d'Hebrón, Barcelona, Spain (J.P., J.M.J., C.M.).

Laura Pardo (L)

Department of Neurology, Hospital Doctor Josep Trueta, Girona, Spain (L.P., J.S.).

Lucía Muñoz-Narbona (L)

From the Department of Neurosciences, Hospital Universitari Germans Trias i Pujol, Neurosciences, Badalona-Barcelona, Spain (M.G., A.D., L.M.-N., J.A.-B.).

Ikram Benabdelhak (I)

Department of Neurology, Hospital Arnau de Vilanova, Lleida, Spain (F.P., I.B.).

Blanca Lara-Rodríguez (B)

Department of Neurology, Hospital de Bellvitge, Hospitalet de Llobregat-Barcelona, Spain (P.C., B.L.-R., A.P).

Elisa Cuadrado-Godia (E)

Department of Neurology, Hospital de Mar, Barcelona, Spain (A.R.-C., E.C.-G., J.R.).

Alejandro Martínez-Domeño (A)

Department of Neurology, Hospital de Sant Pau, Barcelona, Spain (J.M.-F., A.M.-D.).

Jesús Maria Juega (JM)

Department of Neurology, Hospital Vall d'Hebrón, Barcelona, Spain (J.P., J.M.J., C.M.).

Joaquin Serena (J)

Department of Neurology, Hospital Doctor Josep Trueta, Girona, Spain (L.P., J.S.).

Jesús Alvarez-Ballano (J)

From the Department of Neurosciences, Hospital Universitari Germans Trias i Pujol, Neurosciences, Badalona-Barcelona, Spain (M.G., A.D., L.M.-N., J.A.-B.).

Andrés Paipa (A)

Department of Neurology, Hospital de Bellvitge, Hospitalet de Llobregat-Barcelona, Spain (P.C., B.L.-R., A.P).

Jaume Roquer (J)

Department of Neurology, Hospital de Mar, Barcelona, Spain (A.R.-C., E.C.-G., J.R.).

Sònia Abilleira (S)

Stroke Programme, Agency for Health Quality and Assessment of Catalonia, Barcelona, Spain (S.A.).

Rob Neeter (R)

Evina Health Solutions, the Netherlands (R.N., A.v.d.G.).

Abraham van de Groep (A)

Evina Health Solutions, the Netherlands (R.N., A.v.d.G.).

Carlos Molina (C)

Department of Neurology, Hospital Vall d'Hebrón, Barcelona, Spain (J.P., J.M.J., C.M.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH